The use of reninangiotensin system inhibitors, SGLT-2 inhibitors and novel agents, such as finerenone, have also been shown to slow the progression of DKD to end-stage kidney disease and provide CV protection
Springer International Publishing, Cham (2020)
The maximum dose of Ozempic is 2 mg once a week by subcutaneous injection to control blood sugar levels
They do not rule out gallstones, gastroparesis, retinopathy, allergic reactions, bowel problems, or every potential medication complication
Many factors were not controlled for in this study (weight loss, nutritional factors, exercise level etc.)
Written By: Samiksha Jadhav BPharm Reviewed By: Pharmacally Editorial Team Regeneron Pharmaceuticals has reported positive topline results from a Phase 3 clinical trial evaluating olatorepatide, a dual GLP-1/GIP receptor agonist being developed for adults with obesity or overweight